Description
Powered by nature, perfected by science—the ClaraVie™ skin care collection offers a harmonious blend of advanced technology and natural ingredients for radiant, healthy skin.
Claravie Ointment
FDA Label NDC 61554-318
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Gentell Llc for the product Claravie (NDC 61554-318). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding description, active ingredient, purpose, uses, warnings, when using this product, stop use and ask a doctor if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Aluminum Hydroxide Gel 2%
Purpose
Skin Protectant
Uses
Dries the oozing and weeping of poison
- ivy,
- oak &
- sumac
Warnings
For external use only
When Using This Product
do not get in eyes.
Stop Use And Ask A Doctor If
- Condition worsens
- Symptoms last more than 7 days or clear up and occur again within a few days.
Keep Out Of Reach Of Children
In case of accidental ingestion contact a physician or Poison Control Center right away.
Directions
- Apply as needed
- Children under 6 months of age: ask a doctor
Other Information
Store between 59°-86°F (15°-30°C)
Inactive Ingredients
Calcium Carbonate, Cholecalciferol, Citric Acid, Ethylhexylglycerin, Glyceryl Monostearate, Glyceryl Stearate, PEG-100 Stearate, Lanolin, Magnesium Hydroxide, Petrolatum, Phenoxyethanol, Propylene Glycol, Retinyl Palmitate, Sodium Chloride, Sodium Laureth Sulfate, Stearyl Alcohol, Water, Zea Mays Corn Oil, Zinc Chloride
Otc - Questions
- 1-800-840-9041
- www.gentell.com
Dosage & Administration
Apply as needed
Aluminum Hydroxide Gel 2%
Skin protectant Ointment
* Please review the disclaimer below.
